CSPCY (CSPCY) Stock Price & Analysis
CSPCY (CSPCY) rose 0.00% to USD 4.25 as of July 25, 2026 at 01:47 UTC, according to Nexqual real-time market data.
CSPCY last closed at USD 4.25; the session ranged USD 4.23–4.25 on volume of 500 shares. Market capitalization is $12.12B, with a 52-week range of USD 3.26–5.83 (PNK). Source: Nexqual, July 25, 2026 at 01:47 UTC.
Key Statistics (as of July 25, 2026 at 01:47 UTC)
| Price | USD 4.25 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 4.25 |
| Open | USD 4.23 |
| Day Range | USD 4.23 – 4.25 |
| 52-Week Range | USD 3.26 – 5.83 |
| Volume | 500 shares |
| Market Cap | $12.12B |
| Exchange | PNK |
Technical Analysis (CSPCY)
Nexqual's technical model rates CSPCY "BUY" based on 5 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 01:47 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 65.15 (neutral) |
| vs SMA50 | Above (USD 3.8) |
| MACD | 0.14 (positive) |
Analyst Ratings (CSPCY)
Wall Street analysts rate CSPCY "None", per Nexqual as of July 25, 2026 at 01:47 UTC.
| Consensus Rating | None |
|---|
Earnings (CSPCY)
| Revenue Estimate | $8.44B |
|---|
Source: Nexqual, July 25, 2026 at 01:47 UTC.
Financials & Fundamentals (CSPCY)
| Total Revenue | $25.46B |
|---|---|
| Revenue Growth (YoY) | -7.80% |
| Gross Margin | +65.29% |
| Operating Margin | +15.06% |
| Profit Margin | +12.82% |
| ROE | +9.56% |
| Debt / Equity | 1.86 |
| Total Cash | $10.37B |
| Total Debt | $641.11M |
Source: Nexqual, July 25, 2026 at 01:47 UTC.
Financial Health Score (CSPCY)
Nexqual rates CSPCY's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 01:47 UTC.
| Growth | Weak — Revenue -5% YoY (annual), declining |
|---|---|
| Profitability | Strong — Gross margin 65%, operating 15% |
| Balance Sheet | Strong — $10.4B cash vs $641M debt, net cash position |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — ROE 10% |
Ownership (CSPCY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 2.85B |
| Float | 1.91B |
Source: Nexqual, July 25, 2026 at 01:47 UTC.
Leadership (CSPCY)
CSPCY is led by Lei Cai (age 45), CEO & Vice Chairman of the Board, per Nexqual as of July 25, 2026 at 01:47 UTC.
| CEO & Vice Chairman of the Board | Lei Cai (age 45) |
|---|---|
| Executive Chairman | Dongchen Cai (age 71) |
| COO & Vice-Chairman of the Board | Qingjie Wei (age 55) |
| Executive Director & Chief Scientist | Chunlei Li (age 49) |
| Executive Director | Zhenguo Wang (age 55) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OPHLY | Ono Pharmaceutical Co., Ltd. | USD 4.82 | ▼ 0.62% |
| MTHRY | M3, Inc. | USD 5.53 | ▲ 1.13% |
| CHGCY | Chugai Pharmaceutical Co., Ltd. | USD 22 | ▼ 1.57% |
| RCRUY | Recruit Holdings Co., Ltd. | USD 14.66 | ▼ 2.79% |
| SGIOY | Shionogi & Co. Ltd. | USD 8.7 | ▼ 0.57% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:47 UTC. This page is informational and not investment advice.